Nifty

:

14371.90

Sensex

:

48878.54

-218.45 (-1.50%)
-746.22 (-1.50%)

Login

Nifty
Sensex

:
:

14371.90
48878.54

-218.45 (-1.50%)
-746.22 (-1.50%)

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

Rating :

55/99

BSE: 530549 | NSE: SHILPAMED

Watchlist

NSE BSE

428.45

22-Jan-2021

Open
High
Low
Previous Close

435.50
441.85
426.10
433.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

165899
721.01
695.00
233.15

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,494.65
15.78
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,839.97
0.26%
2.39

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.08
4.85
4.80

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.76
6.04
7.24

PAT CAGR (%)

10 Years
5 Years
3 Years

12.23
7.34
11.65

P:E (Median)

8 Years
5 Years
3 Years

26.89
30.44
24.94

P:BV (Average)

8 Years
5 Years
3 Years

4.06
3.98
2.72

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.02
21.37
16.77

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 262.68 236.53 11.06% 216.64 154.56 40.17% 197.93 171.02 15.74% 216.93 157.17 38.02%
Expenses 181.30 161.22 12.46% 139.05 111.59 24.61% 148.66 128.69 15.52% 140.12 127.97 9.49%
EBITDA 81.38 75.31 8.06% 77.59 42.98 80.53% 49.28 42.33 16.42% 76.81 29.20 163.05%
EBIDTM 30.98% 31.84% 35.81% 27.80% -0.29% 24.75% 35.41% 18.58%
Other Income 7.52 2.43 209.47% 2.64 3.43 -23.03% 2.97 3.49 -14.90% 2.47 4.33 -42.96%
Interest 3.34 0.63 430.16% 3.54 1.32 168.18% 1.29 1.01 27.72% 1.09 0.96 13.54%
Depreciation 9.84 8.61 14.29% 9.91 8.57 15.64% 9.16 8.45 8.40% 9.52 10.03 -5.08%
PBT 75.72 68.50 10.54% 119.72 36.52 227.82% 37.26 28.38 31.29% 68.66 16.79 308.93%
Tax 20.95 12.94 61.90% 33.58 7.28 361.26% 11.89 8.75 35.89% 12.05 1.12 975.89%
PAT 54.78 55.56 -1.40% 86.14 29.24 194.60% 25.36 19.63 29.19% 56.61 15.67 261.26%
PATM 20.85% 23.49% 39.76% 18.92% 2.87% 11.48% 26.10% 9.97%
EPS 6.72 6.82 -1.47% 10.57 3.59 194.43% 3.11 2.41 29.05% 6.95 1.92 261.98%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 278.94 289.92 -3.79% 222.87 160.99 38.44% 219.99 199.52 10.26% 236.85 173.43 36.57%
Expenses 210.25 221.91 -5.25% 157.11 132.19 18.85% 174.40 162.11 7.58% 163.11 147.25 10.77%
EBITDA 68.68 68.00 1.00% 65.75 28.80 128.30% 45.60 37.40 21.93% 73.74 26.18 181.67%
EBIDTM 24.62% 23.46% 29.50% 17.89% 14.01% 18.75% 31.13% 15.09%
Other Income 9.20 5.82 58.08% 5.48 1.98 176.77% 8.91 3.09 188.35% 3.25 3.13 3.83%
Interest 3.95 0.82 381.71% 4.00 1.46 173.97% 1.01 1.41 -28.37% 1.27 1.07 18.69%
Depreciation 12.70 10.66 19.14% 12.33 10.66 15.67% 11.55 10.54 9.58% 10.97 11.25 -2.49%
PBT 61.23 62.34 -1.78% 115.74 18.66 520.26% 41.57 28.09 47.99% 64.76 11.24 476.16%
Tax 15.99 11.18 43.02% 29.14 4.05 619.51% 7.55 5.61 34.58% 10.53 -0.46 -
PAT 45.24 51.16 -11.57% 86.60 14.61 492.74% 34.02 22.49 51.27% 54.24 11.70 363.59%
PATM 16.22% 17.65% 38.86% 9.07% 7.11% 11.27% 22.90% 6.75%
EPS 5.57 6.23 -10.59% 10.59 1.93 448.70% 28.29 2.93 865.53% 6.75 1.53 341.18%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 894.18 805.97 663.88 741.29 733.67 675.79 565.40 527.37 328.20 279.76 257.54 Net Sales Growth 24.32% 21.40% -10.44% 1.04% 8.56% 19.52% 7.21% 60.69% 17.31% 8.63% Cost Of Goods Sold 719.41 258.38 229.62 348.45 365.75 359.49 309.52 305.03 205.00 174.56 153.87 Gross Profit 174.77 547.60 434.26 392.85 367.92 316.30 255.88 222.34 123.19 105.20 103.67 GP Margin 19.54% 67.94% 65.41% 53.00% 50.15% 46.80% 45.26% 42.16% 37.54% 37.60% 40.25% Total Expenditure 609.13 568.18 494.86 573.43 560.97 511.35 431.01 409.65 262.79 223.47 188.15 Power & Fuel Cost - 35.31 31.39 27.00 24.56 20.54 17.58 15.55 8.83 7.63 5.65 % Of Sales - 4.38% 4.73% 3.64% 3.35% 3.04% 3.11% 2.95% 2.69% 2.73% 2.19% Employee Cost - 149.28 124.66 113.29 91.53 67.27 56.49 42.13 22.76 16.94 12.85 % Of Sales - 18.52% 18.78% 15.28% 12.48% 9.95% 9.99% 7.99% 6.93% 6.06% 4.99% Manufacturing Exp. - 75.34 55.63 55.48 50.58 42.10 29.78 22.80 13.28 10.20 7.83 % Of Sales - 9.35% 8.38% 7.48% 6.89% 6.23% 5.27% 4.32% 4.05% 3.65% 3.04% General & Admin Exp. - 24.76 16.55 12.15 11.52 9.00 6.57 6.41 7.67 6.45 4.02 % Of Sales - 3.07% 2.49% 1.64% 1.57% 1.33% 1.16% 1.22% 2.34% 2.31% 1.56% Selling & Distn. Exp. - 10.04 6.51 6.00 4.51 7.24 5.83 7.22 4.11 3.03 2.84 % Of Sales - 1.25% 0.98% 0.81% 0.61% 1.07% 1.03% 1.37% 1.25% 1.08% 1.10% Miscellaneous Exp. - 15.07 30.50 11.06 12.52 5.71 5.25 10.51 1.12 4.67 2.84 % Of Sales - 1.87% 4.59% 1.49% 1.71% 0.84% 0.93% 1.99% 0.34% 1.67% 0.42% EBITDA 285.06 237.79 169.02 167.86 172.70 164.44 134.39 117.72 65.41 56.29 69.39 EBITDA Margin 31.88% 29.50% 25.46% 22.64% 23.54% 24.33% 23.77% 22.32% 19.93% 20.12% 26.94% Other Income 15.60 40.02 17.16 34.52 29.82 11.14 7.51 8.85 5.01 7.79 9.10 Interest 9.26 4.33 2.79 2.12 2.79 3.27 3.88 3.40 1.95 1.97 2.27 Depreciation 38.43 34.96 34.01 32.78 26.66 21.19 19.09 21.09 12.75 11.44 10.42 PBT 301.36 238.53 149.38 167.49 173.08 151.12 118.93 102.08 55.72 50.66 65.79 Tax 78.47 40.27 31.49 34.25 41.09 35.84 34.84 21.23 9.65 11.54 14.91 Tax Rate 26.04% 17.21% 20.24% 20.45% 24.38% 24.10% 29.29% 20.80% 17.35% 22.50% 22.66% PAT 222.89 193.72 124.11 133.24 127.45 112.86 84.10 80.86 45.96 39.75 50.88 PAT before Minority Interest 222.89 193.72 124.11 133.24 127.45 112.86 84.10 80.86 45.96 39.75 50.88 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 24.93% 24.04% 18.69% 17.97% 17.37% 16.70% 14.87% 15.33% 14.00% 14.21% 19.76% PAT Growth 85.59% 56.09% -6.85% 4.54% 12.93% 34.20% 4.01% 75.94% 15.62% -21.88% EPS 27.35 23.77 15.23 16.35 15.64 13.85 10.32 9.92 5.64 4.88 6.24

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 958.65 907.91 733.39 788.83 779.16 716.43 613.80 571.38 371.32 318.18 290.29 Net Sales Growth 16.36% 23.80% -7.03% 1.24% 8.76% 16.72% 7.42% 53.88% 16.70% 9.61% Cost Of Goods Sold 4,875.71 277.73 257.03 355.87 371.81 366.19 323.16 313.26 213.95 183.22 162.98 Gross Profit -3,917.06 630.18 476.36 432.95 407.36 350.25 290.63 258.12 157.38 134.96 127.31 GP Margin -408.60% 69.41% 64.95% 54.89% 52.28% 48.89% 47.35% 45.17% 42.38% 42.42% 43.86% Total Expenditure 704.87 693.39 579.39 637.60 617.55 556.44 487.38 455.40 301.63 257.08 219.70 Power & Fuel Cost - 38.76 33.57 28.86 26.30 21.90 19.29 17.37 10.67 9.38 7.03 % Of Sales - 4.27% 4.58% 3.66% 3.38% 3.06% 3.14% 3.04% 2.87% 2.95% 2.42% Employee Cost - 196.59 176.40 149.35 127.87 90.09 82.30 67.83 42.56 33.68 28.37 % Of Sales - 21.65% 24.05% 18.93% 16.41% 12.57% 13.41% 11.87% 11.46% 10.59% 9.77% Manufacturing Exp. - 79.19 61.23 59.96 52.55 45.35 36.55 27.44 16.92 12.89 8.35 % Of Sales - 8.72% 8.35% 7.60% 6.74% 6.33% 5.95% 4.80% 4.56% 4.05% 2.88% General & Admin Exp. - 70.26 27.20 22.50 16.95 14.11 10.64 9.53 9.51 7.87 5.64 % Of Sales - 7.74% 3.71% 2.85% 2.18% 1.97% 1.73% 1.67% 2.56% 2.47% 1.94% Selling & Distn. Exp. - 10.40 6.72 6.37 4.75 7.27 5.99 7.29 4.43 3.19 4.63 % Of Sales - 1.15% 0.92% 0.81% 0.61% 1.01% 0.98% 1.28% 1.19% 1.00% 1.59% Miscellaneous Exp. - 20.47 17.23 14.68 17.32 11.54 9.45 12.68 3.59 6.86 4.63 % Of Sales - 2.25% 2.35% 1.86% 2.22% 1.61% 1.54% 2.22% 0.97% 2.16% 0.93% EBITDA 253.77 214.52 154.00 151.23 161.61 159.99 126.42 115.98 69.69 61.10 70.59 EBITDA Margin 26.47% 23.63% 21.00% 19.17% 20.74% 22.33% 20.60% 20.30% 18.77% 19.20% 24.32% Other Income 26.84 22.22 15.56 32.62 29.34 11.36 6.93 9.12 5.01 8.28 8.95 Interest 10.23 4.56 3.68 2.66 3.13 3.93 4.05 3.52 2.27 2.31 2.63 Depreciation 47.55 43.78 42.06 37.22 30.64 23.14 21.41 23.22 15.34 14.36 12.96 PBT 283.30 188.40 123.82 143.96 157.17 144.28 107.89 98.35 57.10 52.71 63.95 Tax 63.21 33.49 26.18 33.91 42.04 35.62 35.22 20.30 9.53 12.22 14.60 Tax Rate 22.31% 17.78% 18.22% 23.56% 27.54% 25.11% 32.66% 21.27% 16.72% 22.91% 22.83% PAT 220.10 156.50 120.28 112.43 113.71 109.84 73.69 75.67 47.35 41.23 49.35 PAT before Minority Interest 220.74 154.91 117.52 110.05 110.59 106.24 72.62 75.15 47.47 41.11 49.35 Minority Interest 0.64 1.59 2.76 2.38 3.12 3.60 1.07 0.52 -0.12 0.12 0.00 PAT Margin 22.96% 17.24% 16.40% 14.25% 14.59% 15.33% 12.01% 13.24% 12.75% 12.96% 17.00% PAT Growth 120.19% 30.11% 6.98% -1.13% 3.52% 49.06% -2.62% 59.81% 14.84% -16.45% EPS 27.01 19.20 14.76 13.80 13.95 13.48 9.04 9.28 5.81 5.06 6.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,453.42 1,281.55 1,156.98 1,029.62 664.59 563.10 412.56 330.79 287.30 235.21 Share Capital 8.15 8.15 8.15 8.01 7.71 7.71 7.36 4.90 4.90 4.80 Total Reserves 1,445.27 1,273.39 1,148.83 1,021.60 656.88 555.39 405.21 325.88 282.39 226.03 Non-Current Liabilities 208.00 157.15 139.08 241.14 59.29 59.43 65.23 64.16 24.94 27.02 Secured Loans 164.48 80.39 67.08 141.18 0.00 16.23 37.38 43.22 5.07 11.16 Unsecured Loans 0.00 0.70 1.03 1.30 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 8.72 5.36 5.08 5.55 4.32 3.89 0.88 0.31 0.76 0.60 Current Liabilities 359.86 229.59 251.05 219.71 205.32 160.13 149.05 111.97 109.74 68.37 Trade Payables 76.63 71.37 98.86 103.91 98.20 65.58 86.61 47.74 53.13 24.00 Other Current Liabilities 119.85 76.53 56.68 25.20 25.74 38.28 35.64 21.51 18.28 14.27 Short Term Borrowings 156.40 78.72 92.95 88.04 69.59 50.84 22.02 38.92 35.73 27.86 Short Term Provisions 6.97 2.97 2.57 2.55 11.79 5.43 4.78 3.80 2.60 2.24 Total Liabilities 2,021.28 1,668.29 1,547.11 1,490.47 929.20 782.66 626.84 506.92 421.98 330.60 Net Block 517.00 510.84 488.69 448.85 349.77 280.01 257.66 152.56 140.84 127.09 Gross Block 756.00 723.32 666.58 594.31 469.21 378.74 338.75 212.70 188.18 163.00 Accumulated Depreciation 238.99 212.49 177.89 145.46 119.44 98.73 81.09 60.14 47.34 35.90 Non Current Assets 1,113.59 1,147.87 893.90 786.14 597.17 497.66 402.49 324.23 246.74 159.19 Capital Work in Progress 372.81 401.21 200.99 136.51 89.38 87.71 49.24 114.27 55.27 1.25 Non Current Investment 93.48 89.04 111.35 101.78 94.05 74.24 65.07 37.01 33.11 28.08 Long Term Loans & Adv. 124.54 119.95 68.04 94.26 58.65 55.60 30.48 19.99 17.18 2.46 Other Non Current Assets 5.76 26.83 24.83 4.75 5.31 0.08 0.05 0.40 0.34 0.30 Current Assets 907.69 520.42 653.22 704.32 332.03 284.99 224.36 182.69 175.24 171.41 Current Investments 0.00 0.00 119.54 224.62 59.63 65.35 10.14 50.28 68.02 0.00 Inventories 206.23 176.70 167.72 174.96 124.66 120.88 108.95 66.13 59.87 37.44 Sundry Debtors 226.54 181.68 218.14 166.50 111.98 70.12 60.31 31.88 33.19 33.63 Cash & Bank 28.19 90.93 73.14 93.10 5.66 2.49 0.81 10.53 1.95 83.75 Other Current Assets 446.73 55.40 28.59 23.24 30.11 26.15 44.15 23.87 12.22 16.59 Short Term Loans & Adv. 30.17 15.70 46.09 21.91 15.56 4.95 26.77 12.66 5.71 10.51 Net Current Assets 547.83 290.83 402.16 484.62 126.71 124.87 75.31 70.72 65.50 103.04 Total Assets 2,021.28 1,668.29 1,547.12 1,490.46 929.20 782.65 626.85 506.92 421.98 330.60

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,329.36 1,197.58 1,085.03 986.90 639.26 546.94 396.45 320.42 275.98 224.68 Share Capital 8.15 8.15 8.15 8.01 7.71 7.71 7.36 4.90 4.90 4.80 Total Reserves 1,321.21 1,189.43 1,076.88 978.88 631.55 539.23 389.09 315.52 271.07 213.85 Non-Current Liabilities 256.94 166.62 153.48 251.26 67.23 154.15 104.53 98.51 31.13 31.85 Secured Loans 164.48 80.39 67.09 141.20 0.03 71.03 37.43 70.47 5.07 11.42 Unsecured Loans 0.53 0.70 1.03 1.30 0.00 31.30 30.05 0.00 0.00 0.00 Long Term Provisions 26.17 21.77 20.32 16.89 13.96 11.75 9.93 6.92 6.34 5.71 Current Liabilities 407.74 253.44 265.84 236.90 222.07 189.06 166.84 123.77 121.14 80.21 Trade Payables 89.46 80.72 103.74 111.86 106.48 75.50 92.98 51.26 56.72 27.90 Other Current Liabilities 142.11 81.62 59.59 28.03 36.49 49.32 38.23 23.38 20.34 16.65 Short Term Borrowings 165.27 86.58 98.12 92.41 74.10 58.47 30.27 45.07 41.24 33.15 Short Term Provisions 10.90 4.52 4.39 4.60 5.00 5.77 5.37 4.06 2.83 2.51 Total Liabilities 1,986.13 1,610.02 1,499.13 1,472.22 930.89 904.54 677.83 551.42 433.11 338.21 Net Block 650.44 558.01 534.20 491.93 393.41 316.06 294.42 180.67 166.61 146.25 Gross Block 986.42 853.16 793.24 704.89 582.20 476.34 448.38 300.89 271.30 232.84 Accumulated Depreciation 335.98 295.15 259.04 212.96 188.79 160.28 153.96 120.22 104.70 86.59 Non Current Assets 1,365.35 1,064.96 827.16 742.33 576.68 576.77 443.89 339.18 244.95 159.79 Capital Work in Progress 666.25 429.12 209.85 140.51 91.90 221.62 111.03 129.15 57.71 2.72 Non Current Investment 10.45 2.25 20.79 27.99 34.15 0.19 0.21 0.14 0.11 3.65 Long Term Loans & Adv. 32.42 48.75 37.47 77.09 51.86 38.74 38.18 28.82 20.17 6.62 Other Non Current Assets 5.78 26.84 24.86 4.80 5.36 0.16 0.06 0.40 0.34 0.00 Current Assets 620.78 545.06 671.97 729.88 354.21 327.61 233.74 211.99 187.87 178.39 Current Investments 0.00 0.00 119.54 224.62 59.63 65.35 10.14 50.28 68.02 0.00 Inventories 226.43 187.67 188.71 190.00 134.23 130.78 123.25 74.33 67.32 43.33 Sundry Debtors 243.72 203.73 220.27 170.93 125.43 81.37 67.96 41.79 40.53 40.13 Cash & Bank 44.56 94.54 73.83 100.39 11.03 18.42 9.19 16.87 2.27 87.20 Other Current Assets 106.06 45.04 26.08 22.00 23.90 31.69 23.20 28.72 9.72 7.72 Short Term Loans & Adv. 29.25 14.08 43.54 21.95 8.90 4.91 3.23 2.86 3.01 1.56 Net Current Assets 213.04 291.62 406.13 492.98 132.14 138.55 66.90 88.22 66.73 98.18 Total Assets 1,986.13 1,610.02 1,499.13 1,472.21 930.89 904.54 677.83 551.42 433.10 338.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 129.79 164.16 54.46 50.49 119.65 67.35 58.99 35.95 49.57 32.44 PBT 233.99 155.60 167.49 168.53 148.70 118.93 102.08 55.61 51.29 65.84 Adjustment -5.39 25.78 8.68 15.28 18.05 22.61 16.42 8.34 7.28 6.66 Changes in Working Capital -57.95 18.23 -81.25 -99.93 -15.54 -49.19 -38.22 -17.11 -1.22 -27.41 Cash after chg. in Working capital 170.65 199.61 94.92 83.89 151.21 92.35 80.29 46.84 57.35 45.09 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -40.85 -35.45 -40.45 -33.40 -31.55 -25.01 -21.30 -10.89 -7.78 -12.65 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -295.08 -214.71 -12.83 -274.78 -100.98 -139.48 -38.20 -63.04 -144.57 -9.02 Net Fixed Assets -4.28 -256.96 -136.75 -172.23 -92.14 -78.46 -61.02 -83.52 -79.20 -5.23 Net Investments -4.44 141.85 95.51 -172.72 -14.09 -64.38 12.08 13.84 -73.05 -24.39 Others -286.36 -99.60 28.41 70.17 5.25 3.36 10.74 6.64 7.68 20.60 Cash from Financing Activity 170.10 8.17 -61.16 315.27 -14.58 73.82 -30.51 35.67 12.99 58.24 Net Cash Inflow / Outflow 4.82 -42.38 -19.53 90.98 4.09 1.69 -9.72 8.58 -82.01 81.66 Opening Cash & Equivalents 30.76 73.14 92.68 1.70 -3.02 0.81 10.53 1.95 83.96 2.09 Closing Cash & Equivalent 28.19 30.76 73.14 92.68 1.07 2.49 0.81 10.53 1.95 83.75

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 123.72 146.78 44.92 37.48 128.70 68.81 70.04 43.64 56.73 40.86 PBT 188.40 143.70 136.77 146.49 140.36 107.84 95.45 57.00 53.51 64.13 Adjustment 41.32 20.44 18.83 17.19 20.61 26.46 19.62 11.52 10.19 10.42 Changes in Working Capital -63.80 18.71 -69.66 -92.61 -2.70 -40.11 -23.44 -13.90 0.77 -21.04 Cash after chg. in Working capital 165.92 182.85 85.94 71.08 158.27 94.19 91.62 54.62 64.46 53.51 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -42.20 -36.07 -41.02 -33.60 -29.56 -25.38 -21.58 -10.98 -7.73 -12.61 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -288.85 -196.16 -8.76 -262.23 -109.20 -195.18 -48.93 -95.21 -152.31 7.77 Net Fixed Assets -4.28 -256.96 -136.75 -172.23 -92.14 -78.46 -61.02 -83.52 -79.20 -5.23 Net Investments -4.44 141.85 95.51 -172.72 -14.09 -64.38 12.08 13.84 -73.05 -24.39 Others -280.13 -81.05 32.48 82.72 -2.97 -52.34 0.01 -25.53 -0.06 37.39 Cash from Financing Activity 175.50 10.06 -60.91 312.70 -19.65 135.05 -28.34 66.31 10.02 35.93 Net Cash Inflow / Outflow 10.38 -39.32 -24.75 87.95 -0.15 8.68 -7.23 14.74 -85.56 84.56 Opening Cash & Equivalents 34.36 73.83 99.97 7.05 3.61 9.19 16.87 2.27 87.83 2.65 Closing Cash & Equivalent 44.56 34.36 73.83 99.97 6.43 18.42 9.19 16.87 2.27 87.20

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 178.28 157.19 141.91 128.50 86.20 73.03 112.15 89.92 78.10 64.06 ROA 10.50% 7.72% 8.77% 10.53% 13.19% 11.93% 14.26% 9.90% 10.56% 17.77% ROE 14.17% 10.18% 12.19% 15.05% 18.39% 17.24% 21.75% 14.87% 15.34% 29.67% ROCE 14.44% 11.27% 13.00% 16.98% 21.70% 21.49% 22.89% 14.93% 16.97% 29.19% Fixed Asset Turnover 1.09 0.96 1.18 1.39 1.61 1.59 1.94 1.67 1.62 1.65 Receivable days 92.44 109.91 94.36 68.87 48.77 41.69 31.48 35.42 42.78 45.13 Inventory Days 86.71 94.68 84.06 74.10 65.76 73.47 59.79 68.58 62.31 56.19 Payable days 46.77 62.82 63.90 61.73 57.90 62.98 59.11 68.15 62.12 57.27 Cash Conversion Cycle 132.38 141.78 114.52 81.24 56.63 52.19 32.17 35.85 42.98 44.05 Total Debt/Equity 0.26 0.15 0.16 0.23 0.13 0.15 0.19 0.30 0.19 0.22 Interest Cover 55.05 56.69 79.92 61.31 46.45 31.65 31.05 29.59 27.03 29.94

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 163.06 146.89 133.09 123.17 82.91 70.92 107.72 43.52 74.94 60.67 ROA 8.62% 7.56% 7.41% 9.20% 11.58% 9.18% 12.23% 9.64% 10.66% 16.84% ROE 12.26% 10.30% 10.62% 13.60% 17.92% 15.40% 20.98% 15.93% 16.63% 30.96% ROCE 12.41% 11.05% 11.71% 15.91% 19.90% 17.90% 20.48% 15.04% 18.02% 28.98% Fixed Asset Turnover 0.99 0.89 1.06 1.22 1.36 1.34 1.54 1.32 1.28 1.30 Receivable days 89.94 105.51 90.20 69.00 52.26 43.99 34.62 39.70 45.47 46.24 Inventory Days 83.24 93.66 87.32 75.49 66.97 74.84 62.33 68.31 62.38 57.79 Payable days 46.83 58.00 61.51 60.89 60.10 62.86 57.06 63.94 59.10 55.44 Cash Conversion Cycle 126.35 141.17 116.00 83.61 59.13 55.97 39.90 44.07 48.76 48.59 Total Debt/Equity 0.29 0.16 0.18 0.24 0.14 0.34 0.30 0.41 0.22 0.26 Interest Cover 42.34 40.09 55.10 49.69 37.07 27.63 28.09 26.13 24.13 25.28

Top Investors:

tano mauritius india fvci ii

ta fii investors limited

pivotal enterprises private limited

reliance capital trustee co ltd-a/c nippon india pharma fund

duro one investments limited

baring india private equity fund iii listed invest

pivotal business managers llp

Annual Reports:

News Update:

Ind-Ra assigns Shilpa Medicare’s long term rating at ‘A+’
16th Dec 2020, 12:04 PM

The rating agency assigned rating to short term rating at ‘A+’
Read More
Shilpa Medicare - Quarterly Results
2nd Nov 2020, 13:23 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback